Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.

Br J Cancer · 2010 · PMC2865751 · PMID 20372155

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among subgroups of NSAIDs, risk of pancreatic cancer was lowest among users of COX-2 inhibitors and oxicams but the reductions in risk did not reach statistical significance; adjusted ORs (95% CI), 0.80 (0.56–1.11) and 0.67 (0.43–1.03), respectively for use in the 5 years before diagnosis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.